Axogen, Inc. — Director's Dealing 2022

Dec 30, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-12-27

Reporting Person: Zaderej Karen L. (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-27	Common Stock	M	4400	—	Acquired	1012695	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-27	Restricted Stock Units	$	M	4400	Acquired		Common Stock (4400.0)	Direct

Footnotes

F1: This reflects the number of restricted stock units that vested on December 27, 2022.

F2: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3: All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter.